Table 2.
TB Disease-Related Characteristics of the Study Participants Attending the TB Clinic of Madda Walabu University Goba Referral Hospital from January, 2015 to December, 2019
| Variables | Category | Frequency (n) | Proportion (%) |
|---|---|---|---|
| Type of TB | PTB | 205 | 55.0 |
| EPTB | 168 | 45.0 | |
| Smear result | Smear positive | 142 | 38.1 |
| Smear negative | 228 | 61.1 | |
| Unknown | 3 | 0.8 | |
| HIV status | HIV-positive | 65 | 17.4 |
| HIV-negative | 296 | 79.4 | |
| Unknown | 12 | 3.2 | |
| Cotrimoxazole reventive herapy initiated | Yes | 64 | 17.2 |
| No | 251 | 67.3 | |
| Unknown | 58 | 15.5 | |
| Smear result after 2 months | Smear positive | 17 | 4.6 |
| Smear negative | 267 | 71.6 | |
| Unknown | 89 | 23.9 | |
| Anti-TB drug on Intensive phase | RHZE | 365 | 97.9 |
| RHZES | 8 | 2.1 | |
| Anti-TB drug on continuation phase | RH | 357 | 95.7 |
| EH | 16 | 4.3 |
Abbreviations: PTB, pulmonary TB; RHZE, rifampicin, isoniazide, pyrazinamide, ethambutol; RHZES, rifampicin, isoniazide, pyrazinamide, ethambutol, streptomycin; RH, rifampicin, isoniazide; EH, ethambutol, isoniazide.